This should be a cracker with US FDA approval and ready for commercialization. Comparing this with Orthocell with a market cap of 150 million with yet to get US FDA approval, this looks cheap with a diluted market cap of 25 million post raising.
20 cents and raising only 7 million, will be hard to get.
